Encapsulant nanomaterial formed by g-c 3n 4 and chitosan oligomers linked to hydroxyapatite, production method and uses thereof
A ternary complex of g-CsN4, COS, and HAp linked by methacrylic anhydride addresses inefficiencies in wastewater treatment and pest management by providing a nanomaterial for effective encapsulation and controlled release, enhancing bioavailability and offering a sustainable solution for environmental remediation and crop protection.
Patent Information
- Application Number
- PCT/ES2024/070250
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-31
- Filing Date
- 2024-04-22
- Publication Date
- 2024-12-05
AI Technical Summary
Current materials and methods for wastewater treatment and pest management are inefficient and environmentally harmful, and existing nanocarriers lack the necessary characteristics for effective encapsulation and selective release of contaminants and bioactive compounds.
A ternary complex of graphitic carbon nitride (g-CsN4), chitosan oligomers (COS), and hydroxyapatite (HAp) linked by methacrylic anhydride, forming a nanomaterial with encapsulating and photocatalytic properties, allowing for controlled release and enhanced bioavailability of bioactive compounds.
The nanomaterial effectively captures and eliminates contaminants, improves bioavailability of bioactive compounds, and provides a versatile platform for environmental remediation and integrated pest management, offering a sustainable and efficient solution for water purification and crop protection.
Smart Images

Figure IMGF000020_0001 
Figure IMGF000020_0002 
Figure 00000028_0000
Abstract
Description
[0001] DESCRIPTION
[0002] ENCAPSULATING NANOMATERIAL FORMED BY a-C3N4Y CHITOSAN OLIGOMERS LINKED TO HYDROXYAPATITE, OBTAINING PROCESS AND
[0003] USES
[0004] TECHNICAL SECTOR
[0005] The present invention describes a new polymeric nanomaterial based on the union or assembly of mineral and organic components which, due to its encapsulating structure (spheroidal and hollow, typical of a carrier), its size (nanometric) and its presentation (in the form of a film, nanogel or powder), is especially suitable for transporting active ingredients, as well as for the selective release of different compounds, being therefore ideal for the purposes of environmental remediation of water and / or integrated pest management.
[0006] BACKGROUND OF THE INVENTION
[0007] Wastewater treatment, whether by biological, physical, or chemical methods, is a major challenge due to its massive generation, associated cost, and the heterogeneous composition of pollutants. Heavy metals, nitrogenous compounds, pesticides, hydrocarbons, inorganic ions, hydrophobic organic pollutants, detergents, dyes and pigments, pharmaceutical components, and microbial contaminants are widely present in wastewater. All of these can bioaccumulate through food chains and can sometimes have harmful effects on plants, animals, and humans. They have been found to be carcinogenic and mutagenic for living organisms depending on the exposure time and dose.Therefore, various treatment technologies have been proposed to remove high concentrations of contaminants from water, such as electrolysis, ion exchange, chemical precipitation, membrane filtration, and adsorption. Among these methods, adsorption is an attractive option due to its low cost, high efficiency, and flexibility.
[0008] Furthermore, diseases associated with phytopathogenic fungi are responsible for significant economic losses, affecting major herbaceous and woody crops. The conventional method for protecting crops and mitigating the effects of phytopathogens is based on the (often nonspecific) spraying of chemical pesticides. However, the deleterious effects of these products on health and their environmental impact are leading to their gradual banning, making the search for alternatives essential.
[0009] A promising avenue for addressing the aforementioned challenges is the use of nanocarriers. This technology, which has substantially contributed to the development of precision medicine, is also finding applications in agriculture, offering advantages in terms of increased crop production and reduced environmental impact associated with crop protection. Nanocarriers allow the delivery of molecules with biological activity (fertilizers, growth promoters, biorationals, etc.) and their ad hoc release in a time-controlled manner.
[0010] The present invention aims to present a novel polymeric nanomaterial whose unique characteristics enable its application in the capture and elimination of fungi and bacteria, toxins, radioactive metals, and other water pollutants (rivers, wells, fish farms, wastewater treatment plants, etc.); in the formation of new biocomposites or biosensors; as well as in the selective transport (in various media) of biocontrol agents or natural or synthetic bioactive compounds that enable pest control (for example, in agroforestry crops).
[0011] In particular, it is a new ternary complex consisting of graphitic carbon nitride (g-CsN^), chitosan oligomers (COS, with molecular weight between 3000 and 6000 Da), and hydroxyapatite (HAp), linked by methacrylic anhydride (MA) as a crosslinking agent. It is, therefore, a g-CsN^COS-HAp nanomaterial.
[0012] Graphitic carbon nitride (g-CsN) is a visible-light-sensitive polymeric photocatalyst that has become an important material due to its simple, inexpensive, and environmentally friendly preparation methods. It also exhibits good stability and optimal physicochemical properties for use in a wide range of applications. For example, it has been shown to be effective in the degradation of organic pollutants, water disinfection, and bacterial control. The most common precursors used to prepare g-CsN are melamine, dicyandiamide, cyanamide, urea, thiourea, and ammonium thiocyanate. Various methods are available to improve its performance and modulate its properties, such as doping with metal oxides, metal sulfides, noble metals, and carbonaceous nanomaterials.Among the above options, the use of metal oxides is the most common to improve the efficiency of g-CsI^ , for example, by increasing its light absorption in the visible range and reducing the recombination of electrons and holes by promoting the separation of charge carriers.
[0013] On the other hand, chitosan is a linear polysaccharide composed of 3-(1-4)-D-glucosamine (deacetylated units) and N-acetyl-D-glucosamine (acetylated units). Chitosan is obtained from the deacetylation of chitin, a structural component of fungal cell walls, the exoskeleton of arthropods, and components of other invertebrate organisms. Chitosan and its derivatives are naturally occurring polymers that have been the subject of great interest in recent decades, especially for their antimicrobial activity and their biocompatibility, non-toxicity, and biodegradability characteristics. Through different degradation methods, the O-glycosidic bonds between each glucosamine molecule can be broken to generate smaller chains or oligomers of 5 to 10 monomers (chitosan oligomers, SOC), which are more reactive than high molecular weight chitosan.Due to the presence of reactive amino and hydroxyl functional groups, it exhibits excellent film-forming capacity, high water permeability, good adhesion, and susceptibility to chemical modifications. The presence of COS in the g-CsN^COS-HAp system, in addition to conferring flexibility and additional functionalization to the nanoderivative structure, allows the product to be presented in both film and gel form, making it ideal for multipurpose use. In particular, the particles of the g-CsN^COS-HAp aggregate can function simultaneously as encapsulating and surface-transport agents, but ad hoc synthesis allows formulations in which one or the other function predominates.
[0014] Hydroxyapatite (HAp) is a biocompatible inorganic material, the main constituent of bones and teeth, which can also be found in igneous and metamorphic rocks and soil. The activity of HAp is determined by its degree of crystallinity and amphotericity. Specifically, at low crystallinity, the surface area tends to increase, improving the adsorption and removal of heavy metals. Furthermore, at high pH levels, the surface of HAp becomes negatively charged, increasing its performance in the immobilization and oxidation of toxic contaminants. Other factors that also influence its effectiveness include its microstructure, network formation, and porosity. Therefore, due to its excellent biocompatibility and adsorbent properties, HAp can be used as a biosensor for potentially hazardous contaminants in water, food, and the environment.
[0015] Although the possibility of combining g-CsN4 with COS and / or HAp has been described in the state of the art, the compound resulting from the syntheses carried out to date for the g-CsN4-HAp pair (Vishwapriya, II., “Hydroxyapatite-Graphitic Carbon Nitride Based Composites: Synthesis, Characterization, and Evaluation of Bioactivity'', ECS Transactions 2022, 107, 16769-16778) does not have sufficient characteristics to be considered an optimized material for the purposes of, for example, transport, vehiculation and selective deposition. Therefore, there is a need to develop a new process that confers the g-CsN4-HAp pair the characteristics of a nanocarrier and that, at the same time, allows obtaining a material with an encapsulating structure, with a nanometric size and that can be presented as a film, nanogel or powder.
[0016] DESCRIPTION OF THE INVENTION
[0017] A first object of the invention is a polymeric nanomaterial with an encapsulating structure consisting of:
[0018] . Pure g-CsN4 or doped with at least one heteroatom or metal oxide (preferably TiO2) capable of improving its performance by modifying its bandgap (band gap or energy gap) or forming heterojunctions; and
[0019] . chitosan oligomers (of between 5 and 10 monomers) or chito-oligosaccharides (COS) of low molecular weight, understood as a molecular weight between 3000 and 6000 Da, linked by direct bond to hydroxyapatite (HAp); whose assembly is mediated by methacrylic anhydride (MA) as a cross-linking agent, giving rise to a ternary complex g-CsN4-COS-HAp, which can be presented in the form of a film, nanogel or powder, with a nanoparticle size that can range between 50 and 200 nm, and preferably with an average size of 100 nm.
[0020] In general, the molar ratio of the different components of the nanomaterial g-C3N4-COS-HAP can be from 0.5:1:1 to 1:1:1.
[0021] The claimed nanomaterial is, therefore, a new ternary complex consisting of g-CsN4-COS-HAp, with a dendritic structure and nanometric dimensions. Regarding its functionality, it is important to take into account that, among its components, chitosan has a large number of functional groups, such as hydroxyl and amino, and is considered a polycation, since it has a high density of positive charges (which explains its ability to bind to negatively charged molecules). Furthermore, g-C3N4 improves the photocatalytic and biosensor properties of the new biocomposite. Finally, hydroxyapatite is an excellent inorganic material, with multiple uses in agriculture as a source of phosphorus to obtain slow-release fertilizers, for the removal and / or immobilization of heavy metals, or as a biosensor for potentially hazardous contaminants in water, food, and the environment.
[0022] As described above, the particles of the new g-CsN^COS-HAp aggregate can function simultaneously as an encapsulating agent and a surface transport agent. During their synthesis process, one function or the other can be made predominant by hydrating the assembly agent, thereby achieving controlled release of the bioactive compound.
[0023] In particular, the structure of the new nanomaterial is characterized by presenting: i. a spherical morphology;
[0024] i. HAp, suitable for acting as an adsorption agent and biosensor for phosphates and / or heavy metals (Cu, Sr, Ca); iii. g-CsN4, suitable for acting as a photocatalyst and for capturing certain contaminating molecules on the surface (such as rhodamine B or methyl orange); and iv. COS, suitable for encapsulating certain contaminating chemical species (such as copper, iron, and arsenic), as well as biocontrol agents (such as, for example, Bacillus spp. and Trichoderma spp.) or natural or synthetic bioactive compounds (such as extracts of plant species such as Rubia tinctorum, Linearia tomentosa, etc.).
[0025] Among the main advantages of the claimed nanomaterial, the following can be highlighted: i. it is a highly versatile ternary system (g-CsN4-COS-HAp) in that it combines characteristics of a nanocarrier (encapsulant), a photocatalyst and a biosensor (on the surface); i. although the methacrylated binary hybrids g-CsN^AM; HAp-AM and COS-AM have been described in the state of the art, the new material includes, as a novelty, the linking, mediated by methacrylic anhydride, of g-CsI^ , HAp and COS, conferring unprecedented properties to the g-CsN^COS-HAp entity, especially cross-linking. The cross-linking between g-CsN^ COS and HAp, created by the incorporation of methacrylic anhydride, gives the nanomaterial encapsulating capacity (or the capacity to house active products inside); iii.It is capable of improving the solubility and bioavailability of the bioactive compounds whose encapsulation and transport are of interest, without the need to incorporate surfactants or other commonly used chemical compounds. In particular, it has advantages over other vehicle delivery systems for bioactive compounds by avoiding the use of synthetic crosslinking amines and organic solvents and, in addition, presenting high stability in solution; iv. It can house, among others, therapeutic agents with antimicrobial activity that comply with Regulation (EC) No. 1107 / 2009, regarding the marketing of phytosanitary products, and that are suitable for Organic Farming; v. Additionally, the linking of the g-CsN^ COS and HAp moieties by AM has weak binding characteristics, offering the adequate release capacity of the biologically active compounds that it may contain inside.
[0026] In particular embodiments of the invention, the claimed nanomaterial may additionally comprise at least one bioactive compound (BAC), analogously to inclusion complexes. Preferably, said BAC may consist of a compound with antimicrobial activity against phytopathogens. In particular, it may consist of a synthetic agrochemical compound (for example, strobilurins such as azoxystrobin or pyraclostrobin, triazoles such as tebuconazole, or carboxamides such as boscalid, among others) or a natural agent, preferably selected from a polyphenol, a terpene, a terpenic oil, a carotenoid, a fatty acid, an oil, a lignan, a prebiotic, a vitamin or a xanthophyll, as well as any combination thereof. More preferably, the BAC may be a polyphenol or a mixture of polyphenols.
[0027] Preferably, the selected CBA will have at least one functional group capable of binding to the nanomaterial matrix, preferably by hydrogen bonding.
[0028] Thus, the claimed nanomaterial is a ternary complex formed by g-CsI^, chitosan oligomers and hydroxyapatite (g-CsN^COS-HAp), where said complex forms a matrix in which the bioactive compound (CBA) can be inserted, preferably natural extracts or other basic substances referred to in Regulation (EC) No. 1107 / 2009 of the European Parliament and of the Council.
[0029] The union of the CBA to the claimed ternary complex forms a complex analogous to those known as inclusion complexes, whose molar ratio g-CsN4:COS:HAp:CBA is preferably 0.5:1:1:0.25.
[0030] Additionally, the invention relates to a method for obtaining said nanomaterial. Said method may comprise the following steps:
[0031] 1) preparing a solution of high molecular weight chitosan (understood as a molecular weight between 310 and 375 kDa) in preferably distilled water, with a concentration of between 2% and 5% by weight with respect to the total volume, also adding between 70% and 90% by weight of acetic acid or citric acid (preferably of high purity, greater than 98%) with constant stirring at a temperature between 30 and 60 °C. Once the solution is obtained, neutrase is added, preferably in a percentage between 30% and 40% by weight, giving rise to a solution of low molecular weight COS, understood as a molecular weight between 3000 and 6000 Da.Preferably, this stage can be carried out by maintaining the temperature between 30 and 60 °C and applying ultrasound with a frequency between 10 and 20 kHz intermittently (preferably in cycles with sonication of between 10 and 15 minutes, with stops between cycles of between 5 and 10 minutes).
[0032] 2) synthesize a hydrogel of chitosan oligomers modified by a cross-linking agent (methacrylic anhydride). To do this, the cross-linking agent is added to the COS solution obtained in the previous step, preferably in a percentage between 1% and 3% by weight with respect to the total volume of the solution, preferably in the presence of tetrahydrofuran (or, alternatively, dioxane or dichloromethane), preferably in a percentage between 97% and 99% by weight with respect to the total volume of the solution. Preferably, the synthesis process will be carried out by the procedure described in Gupta, B.; Gupta, A.K., “Photocatalytic performance of 3D engineered chitosan hydrogels embedded with sulfur-doped CsN^ZnO nanoparticles for Ciprofloxacin removal: Degradation and mechanistic pathways", International Journal of Biological Macromolecules, 2022, 198, 87-100, with two important modifications: instead of using chitosan, chitosan oligomers will be used and, instead of epichlorohydrin as a cross-linking agent, methacrylic anhydride will be used. The addition of the cross-linking agent modifies the hydroxyl groups of the SOC structure, making them available for interaction with functional groups of the CBA susceptible to encapsulation. Additionally, SOCs have a large number of functional groups, such as hydroxyl and amino, and can be considered polycations, since they have a high density of positive charges, being therefore active in interacting with negatively charged compounds.Preferably, this stage can be carried out at a temperature between 30 and 60 °C and applying ultrasound with a frequency between 10 and 20 kHz intermittently (preferably, alternating cycles with sonication of between 10 and 15 minutes, with cycles without sonication of between 5 and 10 minutes);
[0033] 3) prepare hydroxyapatite modified by a crosslinking agent (methacrylic anhydride). The preparation of HAp is carried out according to the sonication procedure described by Mehta, D., George, S. “Hydroxyapatite: Synthesis and Characterization", Proceedings of International Conference on Materials for the Future - Innovative Materials, Processes, Products and Applications - ICMF 2013, 565-567, with modifications in the sonication conditions (using a frequency between 10 and 20 kHz and alternating sonication cycles of between 10 and 15 minutes with cycles without sonication of between 5 and 10 minutes). In relation to the methacrylation itself, it is preferably carried out by dispersion of the HAp in a solution of AM in tetrahydrofuran (or, alternatively, dioxane or dichloromethane), preferably in THF [by dispersion of 0.5 mL of AM (p=1.035 g / L and Pm=154.16 g / mol) in 25 mL of THF], giving rise to a methacrylated solution of hydroxyapatite;
[0034] 4) synthesizing a porous form of g-CsN4 (pure or doped) modified by a crosslinking agent (methacrylic anhydride), its morphology being close to that of carbon nanotubes, by the reaction of pure or doped g-CsN4 (preferably in a percentage between 84.5% and 90% by weight) with a crosslinking agent (methacrylic anhydride), in a percentage preferably between 0.5% and 1% by weight, in the presence of tetrahydrofuran (or, alternatively, dioxane or dichloromethane), preferably in a percentage between 9% and 15% by weight.Preferably, this stage will be carried out at a temperature between 30 and 60 °C, applying ultrasound with a frequency between 10 and 20 kHz intermittently (preferably in cycles with sonication of between 10 and 15 minutes, separated by cycles without sonication of between 5 and 10 minutes), giving rise to a solution of g-CsN4 modified by the crosslinking agent (preferably methacrylated g-CsN4);
[0035] 5) adding the solution of g-CsN4 modified by the crosslinking agent (preferably, methacrylated g-CsN4), obtained in step 4, to the hydrogel of chitosan oligomers modified by the crosslinking agent (preferably methacrylated COS), obtained in step 2, and finally to the methacrylated solution of hydroxyapatite obtained in step 3, and subjecting the mixture to an ultrasound sonication process, preferably at a temperature between 30 and 60 ° C and applying ultrasound with a frequency between 10 and 20 kHz intermittently (preferably in sonication cycles of between 10 and 15 minutes interspersed with cycles without sonication of between 5 and 10 minutes);
[0036] 6) finally, the complex in solution obtained in the previous step is maintained at a pH preferably between 4 and 5 under stirring, for a preferred period of 24 hours, and is then subjected to a centrifugation and washing process with water (preferably double-distilled and deionized (MilliCi)), thus eliminating the excess crosslinking agent (AM) and giving rise to the g-CsN4-COS-HAp complex, in the form of a hydrogel, with a g-CsN4-COS-HAp molar ratio of between 1:1:1 and 0.5:1:1.
[0037] Thanks to the methacrylation process of chitosan (or its oligomers), its hydroxyl groups are modified, making them available for interaction with functional groups (g-CsN4, CBA, HAp). Furthermore, the sonication process allows for a weak bond between the constituents of the nanomaterial, which will allow the adequate release of the biologically active compounds contained within. In a particular embodiment in which it is desired to form the g-CsN^COS-HAp complex in solid or powder form, an additional final step of lyophilization will be carried out.
[0038] In another particular embodiment of the method described above, the process may comprise an additional step of adding at least one bioactive agent (CBA) to the ternary complex g-CsN^COS-HAp (in solid or hydrogel form), preferably in a weight proportion of between 8 and 10% with respect to the total volume of the solution, preferably followed by a final purification step. Thus, the process may comprise: a) carrying out steps 1 to 5, as previously described, of preparing a solution comprising the g-CsN^COS-HAp complex; b) preparing a solution comprising at least one bioactive compound (CBA), preferably in an aqueous or hydromethanolic medium, with an initial concentration of between 3 and 6 mg / ml (more preferably, 6 mg / ml).In the case of using a hydromethanolic medium, the methane-water mixture will preferably have a 1:1 ratio by volume; c) mixing both solutions and subjecting the mixture to an ultrasound sonication process, preferably at a temperature between 30 and 60 °C and applying ultrasound at a frequency of between 10 and 20 kHz intermittently (preferably in cycles with sonication of between 10 and 15 minutes interspersed with cycles without sonication of between 5 and 10 minutes), to form the g-CsN^COS-HAp-CBA complex. In particular, a dispersion of the bioactive compound (CBA) and the matrix formed by g-CsN^COS-HAp is formed that has characteristics of a colloidal or true solution; and d) isolating the g-CsN^COS-HAp-CBA complex, preferably in a solid state or in the form of a gel.In a particular embodiment in which the final product is isolated in a solid state, this process may preferably be carried out by removing the water or the mixture of water and methanol by vacuum distillation and subsequent lyophilization. In another particular embodiment in which the g-CsI^U-COS-HAp-CBA complex is isolated in the form of a gel or film, the dehydration process may be carried out in silicone molds and an inert atmosphere (N2).
[0039] It should be taken into account that, during the process, the excess methacrylic anhydride in the methacrylation reactions is eliminated by sonication, stirring and / or successive washings, the molar concentration of g-C3N4:COS:HAp being preferably 0.5:1:1 and of g-C3N4:COS:HAp:CBA being 0.5:1:1:0.25.
[0040] Finally, the invention also relates to the use of said nanomaterial in the form of a film, nanogel, or powder. The nanomaterial is designed to be used in a versatile and selective manner in environmental remediation and agriculture, preferably for water purification (in powder form) and / or as a phytosanitary product (in film or nanogel form). Thus, the particles of the claimed nanomaterial can function simultaneously as encapsulating and surface transport agents, and can be designed so that one function or the other predominates. When the complex is used as a powder (for example, for water purification), it will first undergo a lyophilization process. In another particular embodiment, where it is used in the form of a film (for example, as a phytosanitary product), the complex will be previously dehydrated in a controlled manner.
[0041] Las características únicas de este tipo de nanomaterial permiten, por tanto, su aplicación para depurar aguas contaminadas (ríos, pozos, piscifactorías, depuradoras, etc.) através la captura y eliminación de hongos, bacterias, agentetóxicos, herbicidas, materia orgánica (hidrocarburos aromáticos policíclicos (HAP), etc.) o elemento radiativos.
[0042] Additionally, its technical characteristics allow it to be used for the selective transport of active ingredients, improving their solubility and bioavailability, without the need to incorporate surfactants or other commonly used chemical compounds.In this way, it can be used, for example, for the transport of phytosanitary agents, biocontrol agents (biocontrol agents being understood as natural substances that allow the control of pests and diseases in crops) or natural or synthetic bioactive compounds (bioactive compounds being understood as chemical substances found in small quantities in plants and certain foods) in various media, and can be used to control pests in agroforestry crops and / or to treat diseases caused by phytopathogens in plants, both in wood and in their vascular system, as well as fungal diseases (such as lead disease or silver leaf disease, verticillium wilt, bothosphere, septoha or anthracnose) and / or bacterial diseases (such as bacteriosis, cankers, necrosis or bacterial wilt of stone fruit trees).Specifically, the nanomaterial can be applied to crops by spraying, through irrigation, or via endotherapy. In other alternative embodiments, it can be used as a healing paste to protect pruning cuts and / or as a coating for post-harvest treatment during storage, in which case it can be applied in the form of a nanogel.
[0043] In summary, the newly developed nanomaterial can be used in the form of a film, nanogel or powder, and is capable of acting as a multipurpose and selective agent in environmental remediation and integrated pest management, such as -for example- in: (i) biological control; (ii) entrapment or capture, inactivation and elimination of radioactive elements or toxic contaminants in water; (iii) purification and improvement of the quality of wastewater; (iv) carrying out phytosanitary treatments in agroforestry crops, as it is capable of safely and effectively transporting bioactive compounds, both natural and synthetic, or biocontrol agents; and (v) acting as a biosensor of contaminants potentially dangerous to humans, present in water, food and the environment.
[0044] In preferred ratios, the developed nanomaterial with encapsulating capacity can act as a nanocarrier for the delivery / release of therapeutic agents in the treatment of: a) at least one fungus, preferably of the genera Botrytis, Botryosphaeria, Diplodia, Neofusicoccum, Fusarium, Cryphonectria, Dothiorella, Lasidiplodia, Phaeobotryosphaeria, Spencermartinsia, Phaeomoniella, Phaeoacremonium, Codophora, Fomitiporia, Inocutis, Phellinus, Stereum, Eutypa, Eutypella, Cryptosphaeria, Cryptovalsa, Diatrype, Diatrypella, Pleurostomophora and Diaporthe., b) and / or at least one pseudo-fungus, preferably of the genus Phytophthora, such as P. cinnamomi or P. cactorurrr, c) and / or at least one fungus from white rot of wood, preferably of the genus Armillaria.
[0045] Furthermore, if used as a photocatalyst, it can be used to treat: a) contaminated media, for example, by Escherichia coli, methicillin-resistant Staphylococcus aureus (MRSA) or Bacillus anthracis, viruses or microalgae; and / or b) water contaminated by dyes or other recalcitrant contaminants (including radioactive elements). In additional particular embodiments of the invention, the claimed nanomaterial may be used, due to its unique chemical and physical properties, to form biocomposites or biosensors for contaminants that are toxic or potentially hazardous to humans and present in water, food or the environment.
[0046] BRIEF DESCRIPTION OF THE FIGURES
[0047] To complement the description being made, and in order to help better understand the characteristics of the invention, the following figures are attached as an integral part of said description, where, for illustrative and non-limiting purposes, the following has been represented:
[0048] Figure 1. TEM micrographs of C3N4-COS-HAP nanocarriers without encapsulated CBA (left and center) and with encapsulated Linearia tomentosa extract (right). The average size of the nanocarriers is 90 nm.
[0049] . Figure 2.- Diameter (in mm) of B. cinerea mycelium growth at different concentrations (from left to right: 5.62; 8.43; 11.25; 16.87; 22.5; 33.75; 45; 67.5; 90; and 135 pg / mL) of empty g-CsN^COS-HAp nanocarriers and those loaded with a U. tomentosa extract. The same letters above the concentrations indicate that they are not significantly different at p <0.05.
[0050] Figure 3.- Visualization of the evolution of gray rot in uninoculated strawberry fruits (negative control) and artificially inoculated with B. cinerea (untreated, positive control, and treated with two concentrations of the nanomaterial loaded with a CBA) during post-harvest storage.
[0051] PREFERRED DESCRIPTION OF THE INVENTION
[0052] As described above, the present invention relates to a new polymeric nanomaterial, in the form of powder, film or nanogel, comprising: (i) graphitic carbon nitride (g-CsN^ ¡i) chitosan oligomers (COS), and (iii) hydroxyapatite (HAp), using methacrylic anhydride (MA) as a crosslinking or reticulating agent, and optionally (iv) at least one bioactive compound (CBA).
[0053] An important aspect of the present invention is the type of interactions of g-CsN^COS and HAp with each other and with methacrylic anhydride (characterized by infrared spectroscopy). The formation of the methacrylated ternary complex occurs through an ionic gelation process. In particular embodiments in which an active biological compound (BAC) is added, its binding to the nanomaterial occurs through a very weak interaction (hydrogen bond or electrostatic forces), while the interaction with heavy metals occurs by coordination. The action of the applied ultrasound is essential for the appearance of the aforementioned bonds. Otherwise, these bonds do not appear or do so very slowly, making the process unviable.
[0054] In particular, the claimed nanomaterial (which can incorporate antimicrobial bioactive compounds) is water-borne, as, following the ultrasound sonication process, it is nanodispersed, with colloidal or true dissolution characteristics. Additionally, this complex exhibits synergistic activity, meaning that the administration of said nanomaterial improves the parameters against phytopathogens compared to the separate administration of each of its components.
[0055] A series of examples developed to demonstrate the properties of the invention are described below:
[0056] Example 1. Preparation of the nanomaterial obtained by assembling g-CsIS with chitosan oligomers (COS) and hydroxyapatite (HAp) by means of methacrylic anhydride (MA) and its alternative presentation in solid form or as a hydrogel
[0057] Chitosan oligomers (COS) were prepared according to the procedure described in the work of Santos-Moriano et al., “Enzymatic production of fully deacetylated chitooligosaccharides and their neuroprotective and anti-inflammatory properties", Biocatal. Biotransform., 2017, 36, 57-67, with the modifications indicated in Sánchez- Hernández, E. et al., “Lignin-Chitosan Nanocarriers for the Delivery of Bioactive Natural Products against Wood-Decay Phytopathogens'', Agronomy 2022, 12, 461. In brief, chitosan oligomers were prepared from high molecular weight chitosan, 310 to 375 kDa (Hangzhou Simit Chemical Technology Co. Ltd. Hangzhou, China). In the process, 20 g of chitosan were dissolved in 1000 mL of Milli-Q water, adding citric acid with constant stirring at 60 °C and, once dissolved, 1.6 to 1.8 mL of Neutrase® endoprotease (1.67 g / L) were added to degrade the polymer chains.The mixture was subjected to ultrasound at 10 to 20 kHz (preferably in cycles with sonication of between 10 and 15 minutes interspersed with cycles without sonication of between 5 and 10 minutes) to maintain the temperature in the range of 30 to 60 °C. At the end of the process, a solution with a pH in the range of 4 to 6 was obtained with oligomers of molecular weight between 3000 and 6000 Da, with a polydispersity index of 1.6, within the usual range reported in the literature (Tian, M. et al., “Molecular weight dependence of structure and properties of chitosan oligomers'', RSC Advances 2015, 85). The methacrylation of chitosan oligomers (COS) was carried out according to the procedure of Gupta, B.; Gupta, A.K.“Photocatalytic performance of 3D engineered chitosan hydrogels embedded with sulfur-doped CsN^ZnO nanoparticles for Ciprofloxacin removal: Degradation and mechanistic pathways'', International Journal of Biological Macromolecules 2022, 198, 87-100, with two important modifications: chitosan oligomers were used instead of chitosan, and acrylic anhydride (AM) was used instead of epichlorohydrin as a crosslinking agent. Thus, 420 mg of chitosan oligomers were dispersed in an AM solution (w=1.035 g / L and Mw=154.16 g / mol) in THF [by dispersing 0.5 mL of AM in 25 mL of THF]. The mixture was sonicated in cycles of 10 to 15 minutes interspersed with cycles without sonication of between 5 and 10 minutes and with a frequency of 10 to 20 kHz.The methacrylation of chitosan (or its oligomers) modifies the hydroxyl groups and these become available for interaction with functional groups of other co-encapsulating species (lignin, g-CsI^L, HAp, among others) and with bioactive compounds (CBA) susceptible to encapsulation.
[0058] High purity g-CsN4 nanosheets were then obtained from the pyrolysis of melamine cyanurate in a covered crucible under air atmosphere at 600 °C for 50 min, according to the procedure described in Dante, RC et al., “Synthesis of crumpled nanosheets of polymeric carbon nitride from melamine cyanurate”, Journal of Solid State Chemistry, 2013, 201 , 153-163.
[0059] Methacrylation of (doped) g-CsN4 was carried out starting from 210 mg of g-CsN4 dispersed in a solution of methacrylic anhydride (MA, p=1.035 g / L and Mw=154.16 g / mol) in tetrahydrofuran (THF) [by dispersing 0.5 mL of MA in 25 mL of THF]. The mixture was sonicated in cycles of between 10 and 15 minutes interspersed with cycles without sonication of between 5 and 10 minutes and with a frequency of 10 to 20 kHz.
[0060] Next, 1200 mg of hydroxyapatite was methacrylated, following the sonication procedure described by Mehta, D.; George, S. “Hydroxyapatite: Synthesis and Characterization'', Proceedings of International Conference on Materials for the Future - Innovative Materials, Processes, Products and Applications - ICMF 2013, 565-567, with modifications in the frequency and sonication times (the mixture was sonicated in cycles of 10 to 15 minutes interspersed with cycles without sonication of 5 to 10 minutes and with a frequency of 10 to 20 kHz) and the dispersion of HAp in a solution of AM in THF [0.5 mL of AM (w=1.035 g / L and Mw=154.16 g / mol) in 25 mL of THF]. Such sonication generally leads to the formation of fine ceramic powder that has a high porosity (Poinern, GE et al., “Thermal and ultrasonic influence in the formation of nanometer scale hydroxyapatite” bio-ceramic”, International Journal of Nanomedicine 2011, 6, 2083-2095).
[0061] In the next stage, mixing, the methacrylated solution of g-CsN4 was added to the methacrylated solution of COS, drop by drop with stirring, followed by sonication in cycles of between 10 and 15 minutes interspersed with cycles without sonication of between 5 and 10 minutes and with a frequency of 10 to 20 kHz, and stirring was continued for 30 min. To the previous mixture, the methacrylated hydroxyapatite solution was added drop by drop with stirring, followed by sonication for 5 minutes, alternating rest periods of 1 minute, and stirring was continued for 30 min, while controlling both the working temperature [always lower than 60 °C] and the pH [preferably between 4 and 5]. The resulting solution was kept for 24 hours with stirring and, finally, it was centrifuged and successive washes were carried out with double-distilled and deionized water (milli-Q) in order to eliminate excess AM.Finally, the solution was lyophilized, responding to the molar ratio of 0.5:1 :1 g-CsN^COS-HAp.
[0062] In the particular case where the product in hydrogel form is chosen, the preparation of the methacrylated mixture of g-CsN^ COS and Hap is carried out according to the preceding description, but modifying the final stage. In particular, once the solution has been formed and centrifuged, it is poured drop by drop into a 0.5 M aqueous NaOH solution for approximately 30 minutes. The mixture is then subjected to sonication for another 30 minutes, in 5-minute periods. The resulting solution is kept at room temperature for 12 hours under stirring and then washed repeatedly with water. Finally, it is dried for 24 hours at 110 OÍ-
[0063] Example 2: Encapsulation of an extract of Uncaría tomentosa (UT) in g-C3N4-COS-HAp nanocarriers and its formulation in a lyophilized and hydrogel state
[0064] The extract to be encapsulated was obtained from cat's claw bark (Linearia tomentosa) from La Merced, Chanchamayo, Peru. The golden-colored samples were mixed, dried, and ground into a mechanical grinder until a fine powder was obtained. The U. tomentosa powder was mixed with the hydroammoniacal medium in a 1:20 (w / v) ratio and heated in a water bath at 50 °C for 30 min, with sonication cycles of 10 to 15 min interspersed with non-sonication cycles of 5 to 10 min, and at a frequency of 10 to 20 kHz. The solution was centrifuged at 9000 rpm for 15 min and the supernatant was filtered through Whatman No. 1 filter paper. It was then lyophilized to obtain the solid powder used as a bioactive compound to be encapsulated (CBA) in the g-CsN4:COS:HAp complex.To this end, 105 mg of this CBA was added to the aforementioned complex (obtained as described above in Example 1) and the mixture was subjected to sonication in cycles of between 10 and 15 minutes interspersed with cycles without sonication of between 5 and 10 minutes, at a frequency of 10 to 20 kHz, while controlling the working temperature (always below 60 °C) and the pH (between 4 and 5). The resulting solution obeyed the molar ratio g-CsN4:COS:HAp:CBA of 0.5:1 :1 :0.25, the final concentration of CBA being 9%.
[0065] The hydrogels were prepared in the same way, but with an additional step of precipitating the hydrogel with 0.5 M NaOH. The hydrogel was then washed with plenty of water and characterized according to Example 3.
[0066] Regarding the encapsulation efficiency (EE) of the plant extract, it was determined using the indirect method proposed by Fischer, J. et al., “Targeted Drug Delivery in Plants: Enzyme-Responsive Lignin Nanocarriers for the Curative Treatment of the Worldwide Grapevine Trunk Disease Esca”, Advanced Science 2019, 6, 1802315. Briefly, the sample was centrifuged at 10,000 rpm (60 min) and the supernatant containing the non-encapsulated plant extract was first lyophilized, subsequently redissolved in methane-water (1:1, v / v), passed through a 0.2 pm filter and analyzed by high pressure liquid chromatography (HPLC) using an Agilent 1200 series HPLC system. The operating conditions for this analysis were those stipulated in Krizsán et al., “HPLC analysis of anthraquinone derivatives in madder root (Rubia tinctorum) and its cell cultures", Journal of Liquid Chromatography & Related Technologies 2006, 19, 2295-2314: mobile phase of 5% methanol - acetic acid (pH 3) (70 to 30); injection volume of 10 pL; column temperature of 20 °C; flow rate of 0.2 mL / min and detector G1315D, operated at 250 nm. The encapsulation efficiency was determined as EE(%) = (m(initial extract)-m(supernatant extract)) / m(initial extract)) x 100, being higher than 95 %.
[0067] Regarding the release efficiency (RE), the release assays were performed by adding a weighted amount of the nanocarrier (NC) loaded with the lyophilized bioactive compound (BAC) (previously obtained in the encapsulation efficiency assay) and 2.5 U of chitosanase (EC 3.2.1.132) to a methane-water solution (1:1, v / v) under gentle stirring (150 rpm) in the dark for 2 h. An aliquot of the released U. tomentosa extract was taken and analyzed by the same method used to determine the residual (i.e., non-encapsulated) extract. The release efficiency was calculated from the amount of released extract as a percentage of the total amount of encapsulated extract in the NCs, being greater than 80%.
[0068] Example 3: Characterization of the new nanomaterial
[0069] Characterization by Fourier transform infrared spectroscopy (FTIR) and Attenuated Total Reflectance (ATR)
[0070] Infrared vibrational spectra were recorded using a Thermo Scientific Nicolet S50 FTIR spectrometer (Waltham, MA, USA) equipped with an integrated attenuated total reflection (ATR) system. Spectra were recorded with a resolution of 1 cm. -1 in the range of 400-4000 cm -1 , taking the interferograms resulting from the co-addition of 64 scans.
[0071] The spectra of the g-CsN^COS-HAp nanomaterial assembled by AM as a crosslinking agent are shown in Table 1. The presence of bands at 806 and 890 cm -1 It is attributed to the vibrational mode of "breathing" of the tri-s-triazine units and to the deformation mode of the NH bonds, respectively. The bands located between 1100 and 1700 cm -1 are assigned to the typical stretching modes of CN heterocycles, while the bands located between 2200 and 2500 cm -1can be assigned to the presence of a triple or double bond (C=N or C=C). Additionally, the bands at 2800 and 3300 cm -1 are consistent with the NH and / or CH stretching vibration. In addition to the above bands, attributed to g-CsN^, a signal is observed between 900 and 1100 cm -1 corresponding to the PO' groups of hydroxyapatite, thereby confirming its presence in the composite material.
[0072] Table 1. Main bands in the infrared spectrum of the pure g-C3N4-COS-HAp nanomaterial (empty nanocarriers) and after encapsulation of a bioactive compound (CBA) such as the hydromethanolic extract of Uncaría tomentosa.
[0073] Wavenumber (cm -1 )
[0074] 2930 aliphatics (CH and CH3)
[0075] 2897 CH voltage
[0076] 2859 --CH voltage
[0077] 2491 --CH symmetrical tension
[0078] 2360 C=O symmetrical and asymmetrical
[0079] 2345 antisymmetric CO2 tension
[0080] 1628 1629 OH characteristic
[0081] 1718, 1617, 1569 acrylic bending vibration combination -NH
[0082] 1541 1537 and CN strain in amide complexes
[0083] 1074 phosphate
[0084] 920 CH2 asymmetrical plane stress--
[0085] 890 890 deformation C=C
[0086] 806 807 DC axial voltage
[0087] 703 out-of-plane flexion CH
[0088] 563 P-0
[0089] Transmission electron microscopy (TEM) characterization of the methacrylated C3N4-COS-HAp complex alone and after encapsulation of a CBA
[0090] Transmission electron microscopy (TEM) characterization was performed using a JEOL (Akishima, Tokyo, Japan) JEM 1011 HR microscope. Operating conditions: 100 kV; 25,000–120,000x magnification. Micrographs were obtained with a GATAN ES1000W CCD camera (4000 x 2672 pixels). Uranyl acetate (2%) was used for negative staining of the samples. The nanocarriers are shown in Figure 1.
[0091] Example 4: Photocatalytic Activity To evaluate the photocatalytic activity of the nanomaterial g-CsN^COS-HAp, degradation tests of the rhodamine B (RhB) dye were carried out under visible light irradiation (A > 420 nm), following the protocol described by Dong, G.; Zhang, L. “Porous structure-dependent photoreactivity of graphitic carbon nitride under visible light'', Journal of Materials Chemistry 2012, 22, 1160–1166, with minor modifications. Specifically, the experiments were carried out at a higher RhB concentration (10 mg / L instead of 5 mg / L) in the same volume (100 mL). A 300 W xenon lamp with a 420 nm cutoff filter was chosen as the visible light source. g-CsN4-COS-HAp nanocarriers (0.1 g) were dispersed in 100 mL of 10 mg / L RhB aqueous solution in a vessel with a cooling water jacket on the outside.To achieve an adsorption-desorption equilibrium between the tested material and RhB, the solution was stirred in the dark for 2 h. During irradiation, approximately 4 mL of the suspensions were withdrawn at 10-min intervals (over a 2-h period) and subsequently centrifuged to remove nanocarriers. The RhB concentration was determined by absorbance measurements at 550 nm using a Multiskan GO Microplate spectrophotometer (Fisher Scientific). The reaction constant (A) was calculated as ln(C / Co) = -kt, where C is the concentration for each time tested, and Co is the initial concentration when adsorption / desorption equilibrium was reached. The nanomaterial was able to degrade all of the RhB in less than 90 minutes. The reaction constant was approximately 0.03 min. -1 .
[0092] Additional photocatalytic tests on the ability of the g-CsN4-COS-HAp nanomaterial to reduce U(VI) to U(IV) under visible light were performed following the methodology described in Wang, J. et al., “Tunable mesoporous g-Cal nanosheets as a metal-free catalyst for enhanced visible-light-driven photocatalytic reduction of U(VI)'', Chemical Engineering Journal 2020, 383, 123193, with modifications in the quantities used. 30 mg of g-C3N4-COS-HAp was added to 60 mL of UO2(NO3)2 solution at a concentration of 3 mg / L (with 3 mL of methanol as a sacrificial agent). The pH value was adjusted to 6.0. As in the RhB degradation procedure described above, visible light irradiation was obtained from a 300 W Xe lamp equipped with a 5% cut-off filter. 420 nm. Before irradiation, the reaction system was bubbled with N2 in the dark for 2 hours to reach adsorption-desorption equilibrium and maintain anaerobic conditions.During irradiation, 1 mL aliquots of suspension were pipetted off and rapidly filtered. The U(VI) concentration was measured by UV-vis spectrophotometry at 652 nm using Arsenazo III. The photoreaction rate constant ( ) was calculated based on pseudo-first-order kinetics as ln(C / Co) = -kt, where C represents the uranium(VI) concentration at a given time and Co represents the initial concentration. Complete reduction of II(VI) to II(IV) was achieved in less than 45 minutes. The constant k was found to be around 0.2 min. -1 .
[0093] Example 5: Antifungal activity assays of the new nanomaterial g-C3N4-COS-HAp, before and after encapsulation of an extract of Uncaria tomentosa (UT) as CBA
[0094] The g-CsN^COS-HAp nanocarriers, empty (without CBA) and loaded with U. tomentosa extract (with CBA), were tested against B. cinerea. Their antifungal activity was determined by the agar dilution method, according to the standardized procedures for antifungal efficacy testing of the EUCAST (“EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts”), by incorporating aliquots of stock solutions (of empty nanocarriers or those loaded with U. tomentosa extract) in a potato dextrose agar (PDA) medium to obtain concentrations in the range of 62.5 to 1500 pg / mL. 1. Plugs of fungal mycelium ( = 5 mm) were transferred from the margins of a one-week-old B. cinerea culture on PDA to plates incorporating the concentrations mentioned for each treatment (three plates per treatment / concentration, with two replicates each). The plates were incubated at 25 °C in the dark for one week. Unmodified PDA medium was used as a control. Inhibition of mycelial growth was estimated according to the formula ((d c -cfí) / dc) x 100, where d c yd t represent the mean diameters of the control fungal colony and the treated fungal colony, respectively. The effective concentrations (EC50 and EC90) were estimated using PROBIT analysis in IBM SPSS Statistics v.25 software (IBM; Armonk, NY, USA).
[0095] Figure 2 shows the growth diameter of B. cinerea mycelium for empty and U. tomentosa (UT)-loaded g-CsN^COS-HAp nanocarriers. The nanocarrier components exhibit antifungal activity per se, inhibiting the phytopathogen at a concentration of 45 pg / mL, but this activity was improved by encapsulating the U. tomentosa extract, achieving complete inhibition of mycelial growth at a concentration of 22.5 pg / mL. Example 6: Postharvest protection assays on strawberry fruits against B. cinerea infection.
[0096] Under controlled laboratory conditions, the efficacy of C3N4-COS-HAP nanocarriers loaded with U. tomentosa (UT) extract for the post-harvest protection of strawberry fruits of the Fortuna variety, which were artificially inoculated with the phytopathogen, was evaluated. The protocol was slightly modified from that proposed by Sánchez-Hernández et al. “Bark extract of Linearía tomentosa L. for the control of strawberry phytopathogens'', Horticulturae, 2022, 8(8), 672-689, with the application of the treatment in the form of a hydrogel to coat the fruits. The strawberries were disinfected for 2 minutes with a 3% NaOCl solution, then washed three times with sterile distilled water and dried in a laminar flow hood on sterile absorbent paper.Strawberries were randomly distributed into four homogeneous groups of 45 fruits (i.e., three replicates with 15 fruits per replicate and treatment), ensuring that all fruits were in the range of 20-30 g / fruit and were larger than 25 mm in diameter. Two groups were treated with the formulation for which the highest in vitro activity against B. cinerea was recorded in Example 5, i.e., the C3N4-COS-HAP nanocarriers loaded with U. tomentosa (UT) extract, at different concentrations (MIC and MIC*2, i.e., 22.5 and 45 pg / mL), while the other groups served as negative (no treatment and no pathogen) and positive (pathogen and no treatment) controls.Superficial wounds (0 = 5 mm) were made in the equatorial area of each fruit; the strawberries were then immersed in the gel solution of the C3N4-COS-HAP-UT treatment for five minutes and dried at room temperature in a laminar flow hood using sterile absorbent paper. A plug of a PDA culture of B. cinerea (with the mycelium facing the fruit wound) was placed in the superficial wounds. The fruits were placed in covered plastic boxes and stored for seven days at 4 °C and 95–98% RH, and then exposed to a 4-day storage period at 20 °C and 95–98% RH.During storage, the percentage of infected fruits and the severity of the disease were analyzed (according to an empirical scale with six degrees: 0, healthy fruit; 1, 1-20% of infected fruit surface; 2, 21-40% of infected fruit surface; 3, 41-60% of infected fruit surface; 4, 61-80% of infected fruit surface; 5, more than 81% of infected surface with sporulation).
[0097] Regarding quality attributes, firmness was measured in the central area of the strawberries (previously cut in halves) using a TA-XT2 texture analyzer (Stable or Micro Systems, Godalming, United Kingdom) with a 5 mm diameter flat probe. The penetration depth was 5 mm and the crosshead speed was 5 mm / s. The results are presented in Table 2 and Figure 3. At a concentration of 22.5 pg / mL, the treatment prevented disease development until the seventh day, and achieved a notable reduction until the ninth day, but the severity on the eleventh day was significant. At the highest concentration (45 pg / mL), gray rot control improved, managing to maintain the level of damage low until the eleventh day. Table 2. Evolution of gray rot severity in uninoculated strawberry fruits (negative control) and artificially inoculated with B.cinerea (untreated, positive control, and treated with two concentrations of the nanomaterial loaded with a CBA) during post-harvest storage.
[0098] Time Control Control C3N4-COS-HAp-Ut C3N4-COS-HAp-Ut
[0099] (days) negative positive (22.5 pg / mL) (45 pg / mL)
[0100] 1 0 0 0 0 or
[0101] 5 0 0.8 0 0
[0102] 7 0 1 ,3 0 0
[0103] 9 0 3.1 1 0.3
[0104] 1 in 1 0 4.5 3.7 1 .6
Claims
CLAIMS 1. Polymeric nanomaterial with encapsulating capacity characterized by comprising: . pure or doped g-CsN4; and . low molecular weight chitosan oligomers (COS) linked by direct bond to hydroxyapatite (HAp), where said nanomaterial consists of a ternary complex g-CsN^COS-HAp constituted by an assembly of g-CsN^COS and HAp by means of methacrylic anhydride (MA) as a crosslinking agent.
2. Nanomaterial according to claim 1, wherein said nanomaterial is presented in the form of a film, nanogel or powder.
3. Nanomaterial according to claim 1 or 2, wherein the molar ratio of the different components of the nanomaterial g-CsN^COS-HAp varies from 0.5:1:1 to 1:1:
1.
4. Nanomaterial according to any one of claims 1 to 3, wherein said nanomaterial additionally comprises at least one encapsulated bioactive compound (BAC).
5. Nanomaterial according to claim 4, wherein the molar ratio g- C3N4:COS:HAp:CBA is 0.5:1:1:0.
25.
6. Nanomaterial according to claim 4 or 5, wherein the encapsulated bioactive compound is a synthetic agrochemical compound with antimicrobial activity against phytopathogens.
7. Nanomaterial according to claim 4 or 5, wherein the encapsulated bioactive compound is a natural agent selected from a group consisting of polyphenols, terpenes, terpene oils, carotenoids, fatty acids, oils, lignans, prebiotics, vitamins and xanthophylls, as well as any combination thereof.
8. Method for obtaining a nanomaterial according to claim 1, characterized in that it comprises the following steps: 1) preparation of a solution of high molecular weight chitosan in water, with a concentration of between 2% and 5% by weight with respect to the total volume, also adding between 70% and 90% by weight of acetic acid or citric acid with constant stirring where, once the solution is obtained, neutrase is added, giving rise to a solution of low molecular weight COS, 2) addition of a crosslinking agent consisting of methacrylic anhydride to the COS solution obtained in step 1, in the presence of tetrahydrofuran, dioxane or dichloromethane, giving rise to a hydrogel of chitosan oligomers modified by methacrylic anhydride as a crosslinking agent; 3) addition of hydroxyapatite to a solution of methacrylic anhydride in tetrahydrofuran, dioxane or dichloromethane, giving rise to a methacrylic solution of hydroxyapatite; 4) addition of pure or doped g-CsN4 to a solution of methacrylic anhydride in tetrahydrofuran, dioxane or dichloromethane, giving rise to a solution of g-CsN4 modified by methacrylic anhydride; 5) adding the solution of g-CsN4 modified by methacrylic anhydride, obtained in step 4, to the hydrogel of chitosan oligomers modified by methacrylic anhydride, obtained in step 2 and then to the methacrylic hydroxyapatite solution obtained in step 3, and subjecting the mixture to an ultrasound sonication process at a temperature between 30 and 60 ° C, applying ultrasound with a frequency between 10 and 20 kHz intermittently, in sonication cycles of between 10 and 15 minutes interspersed with cycles without sonication of between 5 and 10 minutes, giving rise to a solution of the methacrylic g-CsN4-COS-HAp complex; 6) maintenance of the methacrylic g-CsN4-COS-HAp complex in solution obtained in the previous step 5 at a pH of between 4 and 5 under stirring, then being subjected to a centrifugation and washing process with water, eliminating the excess of methacrylic anhydride and giving rise to the g-CsN4-COS-HAp complex, in the form of a hydrogel, with a g-CsN4-COS-HAp molar ratio of between 1:1:1 and 0.5:1:
1.
9. Method according to claim 8, wherein steps (1) to (3) are carried out at a temperature between 30 and 60 °C and applying ultrasound with a frequency between 10 and 20 kHz intermittently, in sonication cycles of between 10 and 15 minutes interspersed with cycles without sonication of between 5 and 10 minutes.
10. Method according to claim 8 or 9, wherein said method comprises a final step of iophilization, giving rise to the g-CsN^COS-HAp complex in solid or powder form.
11. Method according to claim 8 or 9, wherein said method comprises an additional step of adding at least one bioactive agent (CBA) to the g-CsN^COS-HAp complex by mixing the solution of the methacrylated g-CsN^COS-HAp complex obtained in step (5) with a solution of the bioactive agent (CBA), subjecting the mixture to an ultrasound sonication process, at a temperature between 30 and 60 °C and applying ultrasound with a frequency between 10 and 20 kHz intermittently, in cycles with sonication of between 10 and 15 minutes interspersed with cycles without sonication of between 5 and 10 minutes, giving rise to the g-CsN^COS-HAp-CBA complex in a gel state.
12. Method according to claim 11, wherein said method comprises an additional drying or lyophilization step, giving rise to the g-CsN^COS-HAp-CBA complex in a solid state.
13. Use of a nanomaterial according to any one of claims 1 to 7 for the selective transport of at least one active ingredient or therapeutic agent.
14. Use of a nanomaterial according to any one of claims 1 to 7 for water purification and / or as a phytosanitary agent, being applied to crops by spraying, through irrigation or via endotherapy.
15. Use of a nanomaterial according to any one of claims 1 to 7 to protect crops, being applied as a healing paste on pruning cuts.
16. Use of a nanomaterial according to any one of claims 1 to 7 in the post-harvest treatment of crops, being applied as a protective coating during storage.
17. Use of a nanomaterial according to any one of claims 1 to 7 as a photocatalyst.
18. Use of a nanomaterial according to any one of claims 1 to 7 for the formation of biocomposites or biosensors of toxic or potentially dangerous contaminants for humans.
